Apex Bio
Rewriting the Future of Brain Health
Health Tech & Life Sciences
Stealth Mode
Company Overview
Snapshot
Founded in September 2024 by Rom Zilberberg and Omri Saar, Apex Bio operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing innovative therapeutics for neurodegenerative diseases.
Business overview
Apex Bio is a biotech startup dedicated to developing innovative therapeutics for neurodegenerative diseases within the Health Tech & Life Sciences sector. The company is focused on a novel, disease-modifying platform designed to diagnose and prevent Alzheimer’s disease years before symptoms appear, addressing a critical need in brain health.
Company Intelligence Q&A
- When was Apex Bio founded?
- Apex Bio was founded in September 2024.
- Who are the founders of Apex Bio?
- Apex Bio was founded by Rom Zilberberg, who serves as Co-founder & CEO, and Omri Saar, who is Co-founder & COO.
- What is Apex Bio's primary focus?
- Apex Bio is focused on developing innovative therapeutics for neurodegenerative diseases, specifically a novel, disease-modifying platform designed to diagnose and prevent Alzheimer’s disease.
- In which sector does Apex Bio operate?
- Apex Bio operates within the Health Tech & Life Sciences sector, with a specialization in Pharma & Medical Biotechnology.
- What is the current employee size of Apex Bio?
- Apex Bio currently has 1–10 employees.